Psychedelics should be used to treat depression

| 3rd April 2020
Psychedelics are an effective tool against a number of mental health conditions but have become an unfortunate victim of the global war on drugs.

What is now needed is a combined, multi-level, multidisciplinary program of research.

Psychedelic drugs such as LSD and magic mushrooms should be used to treat depression and alcoholism, a new study has claimed.

According to the report, published in the scientific journal Cell, such psychedelics are an effective tool against a number of mental health conditions but have become an unfortunate victim of the global war on drugs.

The now-banned drugs were regularly used as treatments around the world until about 50 years ago.

Neuroplastic

Now, the government's former chief drugs adviser Professor David Nutt is among the team of scientists behind the study who are calling for "the resurrection of research into the neuroscience and therapeutic application of psychedelics".

"It (would rectify) decades of global research paralysis that emerged as collateral damage from the war on drugs," they write.

The study claims that brain imaging has revealed the "powerful neuroplastic changes" of psychedelics can have numerous long-term benefits for people suffering from a variety of mental health conditions.

"What is now needed is a combined, multi-level, multidisciplinary program of research into the mechanisms underpinning these findings," the report says.

This Author

Brendan Montague is editor of The Ecologist.

Help us keep The Ecologist working for the planet

The Ecologist website is a free service, published by The Resurgence Trust, a UK-based educational charity. We work hard - with a small budget and tiny editorial team - to bring you the wide-ranging, independent journalism we know you value and enjoy, but we need your help. Please make a donation to support The Ecologist platform. Thank you!

Donate to us here